Cargando…
The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis
Patients on maintenance hemodialysis (MHD), which are at high risk of infection by SARS-CoV-2 virus and death due to COVID-19, have been prioritized for vaccination. However, because they were excluded from pivotal studies and have weakened immune responses, it is not known whether these patients ar...
Autores principales: | Espi, Maxime, Charmetant, Xavier, Barba, Thomas, Koppe, Laetitia, Pelletier, Caroline, Kalbacher, Emilie, Chalencon, Elodie, Mathias, Virginie, Ovize, Anne, Cart-Tanneur, Emmanuelle, Bouz, Christine, Pellegrina, Laurence, Morelon, Emmanuel, Fouque, Denis, Juillard, Laurent, Thaunat, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286235/ https://www.ncbi.nlm.nih.gov/pubmed/34284044 http://dx.doi.org/10.1016/j.kint.2021.07.005 |
Ejemplares similares
-
A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis
por: Espi, Maxime, et al.
Publicado: (2022) -
Défaut de réponse humorale et cellulaire à la vaccination anti-SARS-CoV2 à ARNm chez les patients hémodialysés naïfs
por: Espi, M., et al.
Publicado: (2021) -
Rationnel, tolérance et immunogénicité d’une 3(e) dose de vaccin ARNm anti SARS-Cov2 chez les patients hémodialysés chroniques
por: Espi, M., et al.
Publicado: (2021) -
Rapid Waning of Immune Memory Against SARS-CoV-2 in Maintenance Hemodialysis Patients After mRNA Vaccination and Impact of a Booster Dose
por: Espi, Maxime, et al.
Publicado: (2023) -
Predictive factors of a viral neutralizing humoral response after a third dose of COVID-19 mRNA vaccine
por: Charmetant, Xavier, et al.
Publicado: (2022)